Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Κύριος συγγραφέας: | Tania, Umme |
---|---|
Άλλοι συγγραφείς: | Khan, Tanisha |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/18736 |
Παρόμοια τεκμήρια
-
A review on targeted therapies for lung cancer
ανά: Ashraf, Anushey
Έκδοση: (2023) -
Molecules associated with the development of lung cancer
ανά: Rahman, Adree, κ.ά.
Έκδοση: (2023) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
ανά: Paul, Pulock
Έκδοση: (2024) -
Protein biomarkers for Lung Cancer: a bioinformatic approach
ανά: Jeba, Joynob
Έκδοση: (2017) -
Potential of liposomes for the treatment of lung cancer- a review
ανά: Mim, Shanzida
Έκδοση: (2023)